These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 31412748)
1. Decreased Expression of Semaphorin 3A and Semaphorin 7A Levels and Its Association with Systemic Lupus Erythematosus. Wang P; Mao YM; Liu LN; Zhao CN; Li XM; Pan HF Immunol Invest; 2020 Feb; 49(1-2):69-80. PubMed ID: 31412748 [TBL] [Abstract][Full Text] [Related]
2. Semaphorin-3A, Liu LN; Wang P; Zou YF; Xu Z; Cheng J; Zhang Y; Hu W; Pan HF Autoimmunity; 2019 Jun; 52(4):161-167. PubMed ID: 31394943 [No Abstract] [Full Text] [Related]
3. Assessment of semaphorin 3A and semaphorin 7A levels in primary Sjogren's syndrome. Urhan E; Urhan AC; Dogan HO; Sahin A Rheumatol Int; 2023 Jun; 43(6):1087-1092. PubMed ID: 36030414 [TBL] [Abstract][Full Text] [Related]
4. Gene expression of semaphorin-3A, semaphorin-7A, neuropilin-1, plexin-C1, and β1 integrin in treated-multiple sclerosis patients. Shapoori S; Mosayebi G; Ebrahimi Monfared M; Ghazavi A; Khansarinejad B; Farahani I; Ganji A Neurol Res; 2020 Sep; 42(9):783-788. PubMed ID: 32497464 [TBL] [Abstract][Full Text] [Related]
5. [Association of Semaphorin 3A with thrombocytopenia in systemic lupus erythematosus]. Guo Q; Ma XX; Gao H; Shi LJ; Zhong YC; Xie LF; Shao M; Zhang XW Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 52(5):892-896. PubMed ID: 33047725 [TBL] [Abstract][Full Text] [Related]
6. [Expression and Clinical Significance of Semaphorin 3A in serum and mononuclear cells in patients with systemic lupus erythematosus]. Gao H; Ma XX; Guo Q; Zou YD; Zhong YC; Xie LF; Shao M; Zhang XW Zhonghua Yi Xue Za Zhi; 2017 Feb; 97(5):370-374. PubMed ID: 28219195 [No Abstract] [Full Text] [Related]
7. Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus. Vadasz Z; Haj T; Halasz K; Rosner I; Slobodin G; Attias D; Kessel A; Kessler O; Neufeld G; Toubi E Arthritis Res Ther; 2012 Jun; 14(3):R146. PubMed ID: 22697500 [TBL] [Abstract][Full Text] [Related]
8. Low Urine Secretion of Semaphorin3A in Lupus Patients with Proteinuria. Doron R; Merav L; Nasrin E; Adi SD; Elias T; Gleb S; Itzhak R; Michael R; Zahava V Inflammation; 2022 Apr; 45(2):603-609. PubMed ID: 34562225 [TBL] [Abstract][Full Text] [Related]
9. Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions. Costa C; Martínez-Sáez E; Gutiérrez-Franco A; Eixarch H; Castro Z; Ortega-Aznar A; Ramón Y Cajal S; Montalban X; Espejo C Mult Scler; 2015 Nov; 21(13):1632-43. PubMed ID: 26432853 [TBL] [Abstract][Full Text] [Related]
10. Semaphorin 3A - a marker for disease activity and a potential putative disease-modifying treatment in systemic lupus erythematosus. Vadasz Z; Toubi E Lupus; 2012 Oct; 21(12):1266-70. PubMed ID: 22875653 [TBL] [Abstract][Full Text] [Related]
11. Semaphorin 3A: an immunoregulator in systemic sclerosis. Rimar D; Nov Y; Rosner I; Slobodin G; Rozenbaum M; Halasz K; Haj T; Jiries N; Kaly L; Boulman N; Vadasz Z Rheumatol Int; 2015 Oct; 35(10):1625-30. PubMed ID: 25895648 [TBL] [Abstract][Full Text] [Related]
12. Circulating Semaphorin 4D as a Marker for Predicting Radiographic Progression in Patients with Rheumatoid Arthritis. Ha YJ; Han DW; Kim JH; Chung SW; Kang EH; Song YW; Lee YJ Dis Markers; 2018; 2018():2318386. PubMed ID: 30538782 [TBL] [Abstract][Full Text] [Related]
13. Serum semaphorin 7A is associated with the risk of acute atherothrombotic stroke. You T; Zhu Z; Zheng X; Zeng N; Hu S; Liu Y; Ren L; Lu Q; Tang C; Ruan C; Zhang Y; Zhu L J Cell Mol Med; 2019 Apr; 23(4):2901-2906. PubMed ID: 30729666 [TBL] [Abstract][Full Text] [Related]
14. Elevated plasma midkine and pleiotrophin levels in patients with systemic lupus erythematosus. Wu GC; Yuan H; Pan HF; Ye DQ Oncotarget; 2017 Jun; 8(25):40181-40189. PubMed ID: 27903979 [TBL] [Abstract][Full Text] [Related]
15. Semaphorin 7A as a potential immune regulator and promising therapeutic target in rheumatoid arthritis. Xie J; Wang H Arthritis Res Ther; 2017 Jan; 19(1):10. PubMed ID: 28109308 [TBL] [Abstract][Full Text] [Related]
16. A regulatory role for CD72 expression on B cells in systemic lupus erythematosus. Vadasz Z; Haj T; Balbir A; Peri R; Rosner I; Slobodin G; Kessel A; Toubi E Semin Arthritis Rheum; 2014 Jun; 43(6):767-71. PubMed ID: 24461079 [TBL] [Abstract][Full Text] [Related]
17. Semaphorin 4A as a Potential Biomarker for Diagnosis of Systemic Lupus Erythematosus. He R; Tan X; Xiang J; Zhu J; Jiang Y; Liu W; Li Y; Guo B; Xing Y Immunol Invest; 2023 Jan; 52(1):104-116. PubMed ID: 36239661 [TBL] [Abstract][Full Text] [Related]
18. Differential expression of sema3A and sema7A in a murine model of multiple sclerosis: Implications for a therapeutic design. Gutiérrez-Franco A; Costa C; Eixarch H; Castillo M; Medina-Rodríguez EM; Bribián A; de Castro F; Montalban X; Espejo C Clin Immunol; 2016 Feb; 163():22-33. PubMed ID: 26686462 [TBL] [Abstract][Full Text] [Related]
19. A Study on Semaphorin 3A Level in Juvenile-onset Systemic Lupus Erythematosus Patients. Marzouk H; Hesham Ahmed D; Mohamed Abu Shady H; Tarek Abdelrahman Sarhan H; Eldin Mohamed AbdelKader MS Curr Rheumatol Rev; 2024 Jul; ():. PubMed ID: 39034724 [TBL] [Abstract][Full Text] [Related]
20. Expression of circulating Semaphorin3A and its association with inflammation and bone destruction in rheumatoid arthritis. Gao H; Ma XX; Guo Q; Xie LF; Zhong YC; Zhang XW Clin Rheumatol; 2018 Aug; 37(8):2073-2080. PubMed ID: 29656374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]